Could better dosing save critically ill kids?

NCT ID NCT02539407

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at how anti-infective drugs work in critically ill children. The goal is to find the right doses for each child to improve treatment and reduce risks. Researchers will collect blood samples and health data from 3000 children in intensive care or immuno-hematology units.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to safer, more effective dosing guidelines for anti-infectives in critically ill children.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change practice, and results depend on complex data analysis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC IMMUNO-HEMATOLOGY DEPARTMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PEDIATRIC IMMUNO-HEMATOLOGY DEPARTMENT PEDIATRIC INTENSIVE CARE UNIT

Contacts and locations

Locations

Hospital Necker - Enfants Malades (Public Hospitals of Paris)
RECRUITING

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.